Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions - PubMed (original) (raw)
. 2015 Nov;10(11):1538-45.
doi: 10.1097/JTO.0000000000000666.
Yan Lin, Hui-Min Lin, Brenda F Kurland, David O Wilson, Carl R Fuhrman, Arjun Pennathur, Marjorie Romkes, Tomoko Nukui, Jian-Min Yuan, Jill M Siegfried, Brenda Diergaarde
Affiliations
- PMID: 26352532
- PMCID: PMC4636453
- DOI: 10.1097/JTO.0000000000000666
Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions
Joel L Weissfeld et al. J Thorac Oncol. 2015 Nov.
Abstract
Introduction: Genome-wide association studies (GWAS) have consistently identified specific lung cancer susceptibility regions. We evaluated the lung cancer-predictive performance of single-nucleotide polymorphisms (SNPs) in these regions.
Methods: Lung cancer cases (N = 778) and controls (N = 1166) were genotyped for 77 SNPs located in GWAS-identified lung cancer susceptibility regions. Variable selection and model development used stepwise logistic regression and decision-tree analyses. In a subset nested in the Pittsburgh Lung Screening Study, change in area under the receiver operator characteristic curve and net reclassification improvement were used to compare predictions made by risk factor models with and without genetic variables.
Results: Variable selection and model development kept two SNPs in each of three GWAS regions, rs2736100 and rs7727912 in 5p15.33, rs805297 and rs1802127 in 6p21.33, and rs8034191 and rs12440014 in 15q25.1. The ratio of cases to controls was three times higher among subjects with a high-risk genotype in every one as opposed to none of the three GWAS regions (odds ratio, 3.14; 95% confidence interval, 2.02-4.88; adjusted for sex, age, and pack-years). Adding a three-level classified count of GWAS regions with high-risk genotypes to an age and smoking risk factor-only model improved lung cancer prediction by a small amount: area under the receiver operator characteristic curve, 0.725 versus 0.717 (p = 0.056); overall net reclassification improvement was 0.052 across low-, intermediate-, and high- 6-year lung cancer risk categories (<3.0%, 3.0%-4.9%, ≥ 5.0%).
Conclusion: Specifying genotypes for SNPs in three GWAS-identified susceptibility regions improved lung cancer prediction, but probably by an extent too small to affect disease control practice.
Similar articles
- Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. Wang Y, et al. Carcinogenesis. 2010 Feb;31(2):234-8. doi: 10.1093/carcin/bgp287. Epub 2009 Dec 2. Carcinogenesis. 2010. PMID: 19955392 - Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population.
Jaworowska E, Trubicka J, Lener MR, Masojć B, Złowocka-Perłowska E, McKay JD, Renard H, Oszutowska D, Wokołorczyk D, Lubiński J, Grodzki T, Serwatowski P, Nej-Wołosiak K, Tołoczko-Grabarek A, Sikorski A, Słojewski M, Jakubowska A, Cybulski C, Lubiński J, Scott RJ. Jaworowska E, et al. PLoS One. 2011;6(9):e25057. doi: 10.1371/journal.pone.0025057. Epub 2011 Sep 22. PLoS One. 2011. PMID: 21966413 Free PMC article. - Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes.
Wang Y, Wu W, Zhu M, Wang C, Shen W, Cheng Y, Geng L, Li Z, Zhang J, Dai J, Ma H, Chen L, Hu Z, Jin G, Shen H. Wang Y, et al. Int J Cancer. 2018 Apr 15;142(8):1602-1610. doi: 10.1002/ijc.31182. Epub 2017 Dec 12. Int J Cancer. 2018. PMID: 29193083 - Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk.
Wei R, DeVilbiss FT, Liu W. Wei R, et al. J Genet Genomics. 2015 Oct 20;42(10):549-561. doi: 10.1016/j.jgg.2015.08.005. Epub 2015 Sep 14. J Genet Genomics. 2015. PMID: 26554909 Review. - Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.
Liu C, Cui H, Gu D, Zhang M, Fang Y, Chen S, Tang M, Zhang B, Chen H. Liu C, et al. Lung Cancer. 2017 Nov;113:18-29. doi: 10.1016/j.lungcan.2017.08.026. Epub 2017 Sep 1. Lung Cancer. 2017. PMID: 29110844 Review.
Cited by
- The HUNT lung-SNP model: genetic variants plus clinical variables improve lung cancer risk assessment over clinical models.
Nguyen OTD, Fotopoulos I, Nøst TH, Markaki M, Lagani V, Tsamardinos I, Røe OD. Nguyen OTD, et al. J Cancer Res Clin Oncol. 2024 Aug 12;150(8):389. doi: 10.1007/s00432-024-05909-w. J Cancer Res Clin Oncol. 2024. PMID: 39129029 Free PMC article. - Exploring the Role of Vitamin D, Vitamin D-Dependent Proteins, and Vitamin D Receptor Gene Variation in Lung Cancer Risk.
Ciocarlie T, Motofelea AC, Motofelea N, Dutu AG, Crăciun A, Costachescu D, Roi CI, Silaghi CN, Crintea A. Ciocarlie T, et al. Int J Mol Sci. 2024 Jun 17;25(12):6664. doi: 10.3390/ijms25126664. Int J Mol Sci. 2024. PMID: 38928369 Free PMC article. Review. - Missense variants in CYP4B1 associated with increased risk of lung cancer among Chinese Han population.
Yang Y, Yuan S, Yan S, Dong K, Yang Y. Yang Y, et al. World J Surg Oncol. 2023 Nov 11;21(1):352. doi: 10.1186/s12957-023-03223-2. World J Surg Oncol. 2023. PMID: 37950293 Free PMC article. - IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score.
Tang Y, You D, Yi H, Yang S, Zhao Y. Tang Y, et al. Front Genet. 2022 Mar 24;13:801397. doi: 10.3389/fgene.2022.801397. eCollection 2022. Front Genet. 2022. PMID: 35401709 Free PMC article. - Association of smoking and polygenic risk with the incidence of lung cancer: a prospective cohort study.
Zhang P, Chen PL, Li ZH, Zhang A, Zhang XR, Zhang YJ, Liu D, Mao C. Zhang P, et al. Br J Cancer. 2022 Jun;126(11):1637-1646. doi: 10.1038/s41416-022-01736-3. Epub 2022 Feb 22. Br J Cancer. 2022. PMID: 35194190 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical